Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HAE Haemonetics	$62.94 -1.0%	$65.60	$58.80 ▼ $97.97	$3.16B	0.43	667,087 shs	616,718 shs
QDEL QuidelOrtho	$34.11 -2.5%	$39.81	$29.74 ▼ $49.45	$2.30B	0.1	952,808 shs	615,948 shs
STAA STAAR Surgical	$17.60 -0.2%	$19.23	$13.50 ▼ $52.68	$868.12M	0.66	782,608 shs	787,335 shs
XRAY DENTSPLY SIRONA	$14.65 -1.9%	$17.55	$14.61 ▼ $33.02	$2.92B	0.98	3.09 million shs	2.66 million shs

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HAE Haemonetics	+0.99%	-1.40%	-2.83%	-18.48%	-25.43%
QDEL QuidelOrtho	+0.23%	-4.22%	-12.55%	-21.50%	-27.05%
STAA STAAR Surgical	-0.90%	-0.79%	+0.74%	-27.42%	-53.94%
XRAY DENTSPLY SIRONA	+0.07%	-5.44%	-9.73%	-21.29%	-54.99%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
HAE Haemonetics	4.6779 of 5 stars	4.4	3.0	0.0	4.3	3.0	1.7	1.3
QDEL QuidelOrtho	4.3013 of 5 stars	3.3	1.0	0.0	3.8	3.0	1.7	2.5
STAA STAAR Surgical	4.4868 of 5 stars	4.0	2.0	0.0	4.1	3.0	3.3	0.6
XRAY DENTSPLY SIRONA	4.9203 of 5 stars	4.1	2.0	4.2	3.8	3.3	3.3	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HAE Haemonetics	2.78	Moderate Buy	$101.22	60.81% Upside
QDEL QuidelOrtho	2.50	Moderate Buy	$51.20	50.10% Upside
STAA STAAR Surgical	2.00	Hold	$25.29	43.67% Upside
XRAY DENTSPLY SIRONA	2.21	Hold	$23.33	59.27% Upside

Current Analyst Ratings Breakdown

Latest STAA, HAE, XRAY, and QDEL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/18/2025	HAE Haemonetics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$108.00 ➝ $104.00
3/18/2025	STAA STAAR Surgical	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Equal Weight ➝ Equal Weight	$17.00 ➝ $17.00
3/13/2025	XRAY DENTSPLY SIRONA	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$21.00 ➝ $18.00
3/13/2025	XRAY DENTSPLY SIRONA	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold
2/28/2025	XRAY DENTSPLY SIRONA	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$20.00 ➝ $19.00
2/28/2025	XRAY DENTSPLY SIRONA	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$24.00 ➝ $20.00
2/28/2025	XRAY DENTSPLY SIRONA	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$22.00 ➝ $20.00
2/28/2025	XRAY DENTSPLY SIRONA	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$25.00 ➝ $23.00
2/27/2025	STAA STAAR Surgical	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
2/14/2025	XRAY DENTSPLY SIRONA	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Equal Weight	$20.00
2/13/2025	QDEL QuidelOrtho	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$64.00 ➝ $61.00

(Data available from 4/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HAE Haemonetics	$1.37B	2.30	$6.01 per share	10.48	$18.05 per share	3.49
QDEL QuidelOrtho	$2.78B	0.83	$26.44 per share	1.29	$44.75 per share	0.76
STAA STAAR Surgical	$313.90M	2.77	$0.76 per share	23.02	$7.91 per share	2.23
XRAY DENTSPLY SIRONA	$3.79B	0.77	$3.74 per share	3.92	$15.55 per share	0.94

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HAE Haemonetics	$117.56M	$2.54	24.78	12.49	1.11	9.47%	23.66%	8.82%	5/8/2025 (Estimated)
QDEL QuidelOrtho	-$2.03B	-$30.28	N/A	10.63	N/A	-72.84%	3.78%	1.80%	5/14/2025 (Estimated)
STAA STAAR Surgical	-$20.21M	-$0.41	N/A	N/A	N/A	-6.44%	-3.35%	-2.67%	5/6/2025 (Estimated)
XRAY DENTSPLY SIRONA	-$132M	-$4.55	N/A	7.71	1.80	-10.59%	12.62%	5.45%	5/1/2025 (Estimated)

Latest STAA, HAE, XRAY, and QDEL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/12/2025	Q4 2024	QDEL QuidelOrtho	$1.07	$0.63	-$0.44	-$2.28	N/A	N/A
2/6/2025	Q3 2025	HAE Haemonetics	$1.20	$1.19	-$0.01	$0.74	$354.46 million	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
HAE Haemonetics	N/A	N/A	N/A	N/A	N/A
QDEL QuidelOrtho	N/A	N/A	N/A	N/A	N/A
STAA STAAR Surgical	N/A	N/A	N/A	N/A	N/A
XRAY DENTSPLY SIRONA	$0.64	4.37%	+14.17%	N/A	13 Years

Latest STAA, HAE, XRAY, and QDEL Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/26/2025	XRAY DENTSPLY SIRONA	quarterly	$0.16	3.4%	3/28/2025	3/28/2025	4/11/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HAE Haemonetics	1.35	3.97	2.55
QDEL QuidelOrtho	0.71	1.22	0.69
STAA STAAR Surgical	N/A	5.99	5.38
XRAY DENTSPLY SIRONA	0.72	1.25	0.84

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HAE Haemonetics	99.67%
QDEL QuidelOrtho	99.00%
STAA STAAR Surgical	96.70%
XRAY DENTSPLY SIRONA	95.70%

Insider Ownership

Company	Insider Ownership
HAE Haemonetics	1.80%
QDEL QuidelOrtho	1.00%
STAA STAAR Surgical	1.00%
XRAY DENTSPLY SIRONA	0.52%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HAE Haemonetics	2,820	50.24 million	49.33 million	Optionable
QDEL QuidelOrtho	7,000	67.45 million	66.58 million	Optionable
STAA STAAR Surgical	960	49.33 million	48.78 million	Optionable
XRAY DENTSPLY SIRONA	15,000	198.99 million	197.75 million	Optionable

STAA, HAE, XRAY, and QDEL Headlines

Recent News About These Companies

DENTSPLY SIRONA (NASDAQ:XRAY) Sets New 1-Year Low - Time to Sell?

April 1 at 12:21 PM | marketbeat.com

Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Stockholders to Inquire about Securities Investigation

April 1 at 10:00 AM | accessnewswire.com

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Bought by Edmond DE Rothschild Holding S.A.

April 1 at 6:22 AM | marketbeat.com

531,590 Shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Bought by Skba Capital Management LLC

April 1 at 5:52 AM | marketbeat.com

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Acquired by Prudential Financial Inc.

April 1 at 3:55 AM | marketbeat.com

Dentsply Sirona files automatic mixed securities shelf

March 31 at 11:47 PM | markets.businessinsider.com

Sei Investments Co. Sells 139,855 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

March 31 at 3:30 AM | marketbeat.com

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Short Interest Up 31.1% in March

March 31 at 1:12 AM | marketbeat.com

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Investors to Learn More About the Investigation

March 30 at 10:00 AM | accessnewswire.com

Artisan Partners Limited Partnership Buys 95,549 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

March 30 at 4:59 AM | marketbeat.com

Financial Counselors Inc. Has $659,000 Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

March 30 at 4:41 AM | marketbeat.com

Heartland Advisors Inc. Purchases 161,653 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

March 29 at 7:20 AM | marketbeat.com

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Holdings Boosted by Nuance Investments LLC

March 27, 2025 | marketbeat.com

American Century Companies Inc. Buys 1,071,604 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

March 26, 2025 | marketbeat.com

Thrivent Financial for Lutherans Lowers Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

March 26, 2025 | marketbeat.com

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of "Hold" from Brokerages

March 26, 2025 | marketbeat.com

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dentsply Sirona Inc. (XRAY) And Encourages Stockholders to Reach Out

March 25, 2025 | accessnewswire.com

Proficio Capital Partners LLC Takes Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

March 25, 2025 | marketbeat.com

DENTSPLY SIRONA Q1 EPS Estimate Reduced by Zacks Research

March 25, 2025 | americanbankingnews.com

Sciencast Management LP Acquires 48,676 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

March 24, 2025 | marketbeat.com

Zacks Research Expects Lower Earnings for DENTSPLY SIRONA

March 24, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Warren Buffett Swaps VOO for This Reliable Dividend Stock
By Sarah Horvath | March 7, 2025
View Warren Buffett Swaps VOO for This Reliable Dividend Stock
NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
By Thomas Hughes | March 12, 2025
View NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
By Jeffrey Neal Johnson | March 21, 2025
View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
3 Defense Stocks Set to Benefit From Increased Military Spending
By Chris Markoch | March 20, 2025
View 3 Defense Stocks Set to Benefit From Increased Military Spending
One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
By Gabriel Osorio-Mazilli | March 9, 2025
View One Must-Buy Stock and One to Avoid as Tariffs Shake the Market

STAA, HAE, XRAY, and QDEL Company Descriptions

Haemonetics NYSE:HAE

$62.94 -0.61 (-0.95%)

Closing price 03:59 PM Eastern

Extended Trading

$63.01 +0.06 (+0.10%)

As of 07:28 PM Eastern

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

QuidelOrtho NASDAQ:QDEL

$34.11 -0.86 (-2.46%)

Closing price 04:00 PM Eastern

Extended Trading

$34.11 0.00 (-0.01%)

As of 04:57 PM Eastern

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

STAAR Surgical NASDAQ:STAA

$17.60 -0.03 (-0.17%)

Closing price 04:00 PM Eastern

Extended Trading

$17.54 -0.07 (-0.37%)

As of 04:20 PM Eastern

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

DENTSPLY SIRONA NASDAQ:XRAY

$14.65 -0.29 (-1.94%)

Closing price 04:00 PM Eastern

Extended Trading

$14.84 +0.20 (+1.33%)

As of 05:53 PM Eastern

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time